Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting
NCT ID: NCT02786576
Last Updated: 2020-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2016-07-05
2019-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
NCT00918255
Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa
NCT01468207
Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
NCT02808975
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
NCT01635764
To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
NCT00827996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants receiving adalimumab
Hidradenitis Suppurativa (HS) participants receiving adalimumab
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The decision to treat with adalimumab (Humira) is made by the physician in accordance with the local label (Summary of Product Characteristics; product label) prior to any decision to approach the participant to participate in this study
* Participants willing to be involved in the study and to sign patient authorization form to use and disclose personal health information (or informed consent, where applicable)
Exclusion Criteria
* Participants treated with adalimumab prior to baseline visit
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AbbVie Inc.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Krankenanstalt Rudolfstiftung /ID# 166804
Vienna, Vienna, Austria
LKH-Univ. Klinikum Graz /ID# 166802
Graz, , Austria
Klinikum Wels - Grieskirchen /ID# 158017
Wels, , Austria
UZ Brussel /ID# 154218
Jette, Brussels Capital, Belgium
Cliniques Universitaires Saint Luc /ID# 154217
Woluwe-Saint-Lambert, Brussels Capital, Belgium
CHU de Liege /ID# 154220
Liège, Liege, Belgium
UZ Gent /ID# 154221
Ghent, Oost-Vlaanderen, Belgium
CLIDERM Bruxelles /ID# 154232
Anderlecht, , Belgium
PP Anderlecht /ID# 154230
Anderlecht, , Belgium
CHIREC- City Clinic Louise /ID# 154227
Brussels, , Belgium
ULB Erasme /ID# 154216
Brussels, , Belgium
UZ Antwerp /ID# 154219
Edegem, , Belgium
Boonen, Geel, BE /ID# 154233
Geel, , Belgium
Coenen, Hasselt, BE /ID# 154234
Hasselt, , Belgium
Polyclinique de Herstal /ID# 154226
Herstal, , Belgium
Meuleman, Lede, BE /ID# 154238
Lede, , Belgium
Grand Hopital de Charleroi /ID# 154222
Loverval, , Belgium
Lanssens MD Maldegem BE /ID# 154237
Maldegem, , Belgium
C.H.U.de Mons Borinage /ID# 154215
Mons, , Belgium
Dr. Pierre-Dominique Ghislain, Mons, BE /ID# 154228
Mons, , Belgium
CHU UCL Namur /ID# 154223
Namur, , Belgium
CHU UCL Namur /ID# 154224
Namur, , Belgium
Ctr Hosp du Bois de l'Abbaye /ID# 154235
Seraing, , Belgium
Lecuyer, Thuin, Belgium /ID# 154229
Thuin, , Belgium
AZ Sint-Rembert Ziekenhuis /ID# 154231
Torhout, , Belgium
Centre Medical 4 sapins /ID# 154236
Wavre, , Belgium
Sanatorium, s.r.o /ID# 163593
Chotoviny, , Czechia
Vojenska nemocnice /ID# 163592
Olomouc, , Czechia
Kozni sanatorium /ID# 163591
Prague, , Czechia
Kurzen, Freising, DE /ID# 153913
Freising, , Germany
University General Hospital Attikon /ID# 156761
Athens, Attica, Greece
General Uni hosp of Larissa /ID# 156734
Larissa, Thessaly, Greece
Duplicate_General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens P /ID# 156762
Athens, , Greece
251 Airforce General Hospital /ID# 156731
Athens, , Greece
Genl Hospital Andreas Syggros /ID# 156759
Athens, , Greece
Genl Hospital Andreas Syggros /ID# 156760
Athens, , Greece
University Gen Hosp of Patra /ID# 156735
Pátrai, , Greece
General Hospital of Thessaloni /ID# 156728
Thessaloniki, , Greece
General Hospital of Thessaloniki George Papanikolaou /ID# 156758
Thessaloniki, , Greece
401 GSNA - 401 Army Gen Hosp /ID# 156729
Αthens, , Greece
Miskolci Semmelweis Korhaz es /ID# 153175
Miskolc, Borsod-Abauj Zemplen county, Hungary
Pecsi Tudomanyegyetem /ID# 152612
Pécs, Pecs, Hungary
Markusovszky Egyetemi Oktatókórház /ID# 152616
Szombathely, Vas County, Hungary
Semmelweis Egyetem /ID# 152613
Budapest, , Hungary
Debreceni Egyetem Klinikai Központ /ID# 152615
Debrecen, , Hungary
Somogy Megyei Kaposi Mor Oktat /ID# 160782
Kaposvár, , Hungary
Bacs-Kiskun Megyei Korhaz /ID# 153180
Kecskemét, , Hungary
Szegedi Tudomanyegyetem /ID# 152614
Szeged, , Hungary
South Infirmary Victoria Univ /ID# 151095
Cork, , Ireland
St Vincent's University Hosp /ID# 151084
Dublin, , Ireland
Adelaide and Meath Hosp,IE /ID# 151096
Dublin, , Ireland
Galway University Hospital /ID# 151097
Galway, , Ireland
University Hospital Waterford /ID# 153191
Waterford, , Ireland
Rabin Medical Center /ID# 149530
Petakh Tikva, Tel Aviv, Israel
Tel Aviv Sourasky Medical Ctr /ID# 149528
Tel Aviv, Tel Aviv, Israel
HaEmek Medical Center /ID# 164387
Afula, , Israel
Rambam Health Care Campus /ID# 149529
Haifa, , Israel
Hadassah University Hospital /ID# 149532
Jerusalem, , Israel
Sheba Medical Center /ID# 149531
Ramat Gan, , Israel
Rizk Hospital /ID# 166027
Beirut, , Lebanon
Saint Georges Hosp Med Cent /ID# 166024
Beirut, , Lebanon
American Uni of Beirut Med Cen /ID# 166026
Beirut, , Lebanon
Trad Hospital and Medical Cent /ID# 166025
Beirut, , Lebanon
C/O Hotel Dieu de France /ID# 166028
Beirut, , Lebanon
General Hospital Celje /ID# 164673
Celje, , Slovenia
Univ Medical Ctr Ljubljana /ID# 164671
Ljubljana, , Slovenia
University Medical Ctr Maribor /ID# 164672
Maribor, , Slovenia
GH Novo Mesto /ID# 164674
Novo Mesto, , Slovenia
Hopitaux Universitaires de Geneve /ID# 160090
Geneva, Canton of Geneva, Switzerland
Inselspital, Universitaetsklinik /ID# 160089
Bern, , Switzerland
University Hospital Zurich /ID# 160091
Zurich, , Switzerland
Marmara University Med Faculty /ID# 157903
Istanbul, , Turkey (Türkiye)
Whipps Cross Univ Hospital /ID# 150195
London, London, City of, United Kingdom
NHS Lanakshire (Monklands) /ID# 152885
Airdire, , United Kingdom
Belfast City Hospital /ID# 168411
Belfast, , United Kingdom
Univ Hospitals Birmingham NHS Foundation trust /ID# 152884
Birmingham, , United Kingdom
Heartlands Hospital /ID# 168409
Birmingham, , United Kingdom
Ninewells Hospital /ID# 168410
Dundee, , United Kingdom
Hull and East Yorkshire NHS /ID# 168413
Hull, , United Kingdom
St. James University Hospital /ID# 150200
Leeds, , United Kingdom
St. John's Institute of Dermat /ID# 150197
London, , United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust' /ID# 150199
Newcastle upon Tyne, , United Kingdom
Norfolk and Norwich Univ Hosp /ID# 168412
Norwich, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
clinical study report synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P15-769
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.